홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → 4-(3-Aminoazetidin-1-yl)-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one

HRID 536532
인쇄

반응식

HRID 536532 반응식
Cl.C(OC(=O)[NH:8][CH:9]1[CH2:12][N:11]([C:13]2[C:14]3[C:38]([CH3:40])([CH3:39])[C:37](=[O:41])[NH:36][C:15]=3[N:16]=[C:17]([C:19]3[C:27]4[C:22](=[N:23][CH:24]=[CH:25][CH:26]=4)[N:21]([CH2:28][C:29]4[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=4[F:35])[N:20]=3)[N:18]=2)[CH2:10]1)(C)(C)C>C(OCC)C>[NH2:8][CH:9]1[CH2:10][N:11]([C:13]2[C:14]3[C:38]([CH3:39])([CH3:40])[C:37](=[O:41])[NH:36][C:15]=3[N:16]=[C:17]([C:19]3[C:27]4[C:22](=[N:23][CH:24]=[CH:25][CH:26]=4)[N:21]([CH2:28][C:29]4[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=4[F:35])[N:20]=3)[N:18]=2)[CH2:12]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 313Hydrochloric AcidHCID 71290302tert.-Butyl-(1-{2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl}azetidin-3-yl)carbamate

생성물 1

HCID 712857714-(3-Aminoazetidin-1-yl)-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one

시약·촉매·용매 1

HCID 3283Diethyl Ether용매

실험 절차

0.66 ml of a 2N solution of hydrogen chloride in diethyl ether was added to 81 mg (0.13 mmol; purity 91%) of tert.-butyl-(1-[2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]azetidin-3-yl)carbamate (example 62A) and it was stirred for 4 h at room temperature. The reaction solution was concentrated by evaporation and purified twice by preparative HPLC (acetonitrile/water (+0.1% trifluoroacetic acid) gradient). The concentrated fractions were dissolved in dichloromethane and washed twice with saturated aqueous sodium hydrogen carbonate solution. The combined aqueous phases were extracted twice with dichloromethane. The combined organic phases were dried over sodium sulphate, filtered and concentrated by evaporation. 31 mg (49% of theor.) of the target compound was obtained.

후처리

  1. concentrationThe reaction solution was concentrated by evaporation
  2. custompurified twice by preparative HPLC (acetonitrile/water (+0.1% trifluoroacetic acid) gradient)
  3. dissolutionThe concentrated fractions were dissolved in dichloromethane
  4. washwashed twice with saturated aqueous sodium hydrogen carbonate solution
  5. extractionThe combined aqueous phases were extracted twice with dichloromethane
  6. dry with materialThe combined organic phases were dried over sodium sulphate
  7. filtrationfiltered
  8. concentrationconcentrated by evaporation
  9. custom31 mg (49% of theor.) of the target compound was obtained

출처 및 근거

ORD 기록
ord-50f58b52677f4bf184d8420b134ccb3b
출처 데이터셋
uspto-grants-2014_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08859569B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트